Sign in: Staff/Students
The University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have launched a new joint centre that aims to address the urgent need to develop new antimicrobials and accelerate solutions for existing and emerging infections.
Translating research from across these two world-leading institutions, the Centre of Excellence in Infectious Diseases Research (CEIDR), has been created to develop innovative healthcare and medical technologies to improve healthcare at global and local levels.
Utilising a range of highly specialised facilities that accommodate the full lifecycle of discovery, development and deployment CEIDR will work with the NHS and industry to capitalise on the expertise and research within the institutions, allowing partners to simplify the R&D processes and reduce time and cost in order to accelerate new products into the marketplace.
Professor Bob Burgoyne, Executive Pro-Vice-Chancellor for Health and Life Sciences at the University of Liverpool, along with LSTM’s Director, Professor Janet Hemingway, welcomed partners and invited guests to the launch event at LSTM and introduced them to CEIDR’s vision to address the some of the most significant challenges in global healthcare today.
Professor Burgoyne, said: “Liverpool’s infection research is unique in the UK bringing together the co-location of veterinary, medicine and tropical medicine along with a focus on later stage R&D and one of the highest densities of Cat III facilities in the UK.
“Along with our partners we can provide access to world-class facilities, know-how and funding for those looking to develop products for the diagnosis, prevention or treatment of infectious diseases.”
During the introduction Professors Hemingway and Burgoyne talked about the new approaches that were needed in order to address these challenges such as the development of new antimicrobials, vaccines and immunotherapy as well as improved diagnostics and control tools for vector-borne diseases.
Professor Hemingway added: “Infectious diseases cause a high burden of morbidity and mortality all over the world, which places a substantial strain on limited health budgets, health systems and economies.
“Here in Liverpool we have the largest concentration of translationally-focused expertise in infectious diseases, and working with partners we will be able to take that expertise from where it begins in the lab and deliver it to those people who need it most.”
The centre will utilise space in the new £24m Liverpool Life Sciences Accelerator building, due to be opened later this year and will stand within The Knowledge Quarter Liverpool, home to some of the world’s most influential players in science, health, technology, culture and education.
You can learn more about CEIDR here or by downloading its current brochure.
You must be logged in to post a comment.
All recent news
Explore hidden world of microbes in new comic book
Engineers partner in `Smarter Testing’ project for aerospace sector
Event: How can we change our fashion consumption to become more sustainable?
Student stories: Industry placements
First patient dosed in latest stage of AGILE COVID-19 drug trial
Our paper on immune responses to COVID vaccine (mostly Pfizer) in 237 healthcare workers, 124 #SARSCoV2 naïve and 113 previously infected, from the PITCH consortium @pitchstudy is out as a pre-print today.
See if you can spot us in the new @NetflixUK series, The Irregulars! 📽️
Our @VictoriaGallery appears in it, as well as other locations across the city including St George’s Plateau, the Palm House in Sefton Park and Falkner Street in the Georgian Quarter.
Professor Michael Parkinson CBE, author of 1985's Liverpool on the Brink, and Liverpool Beyond the Brink in 2019, analyses the Caller Report, the Gov's Best Value inspection into Liverpool City Council